On 3/31/2017, Shares of Pluristem Therapeutics, Inc. (NASDAQ:PSTI) closed at $1.23 in last trading day. After noting the initial trading entry at $1.23, it reached to a day’s high of $1.23 and moved to a day’s low of $1.21. The recent daily volume was 422.82 thousand as contrast to it’s an average volume of 461.8 thousand.
The last close of the Pluristem Therapeutics, Inc. stock reflects that it traded up +5.62% from its 50-day moving average of $1.16. The stock traded below -12.00% to its 200-day MA of $1.40. Furthermore, it moved lower -33.51% from its 52-week high of $1.85 and +18.27% up from $1.04, which is 52-week low of the stock.
Pluristem Therapeutics Inc.’s (PSTI) moved with shift of 1.65% in the past week. Over the last three months, the shares of the company have changed -16.33% and performed -20.65% over the last six months. The stock currently has Monthly Volatility of 3.48% and Weekly Volatility of 2.88%.
Pluristem Therapeutics Inc., through its subsidiary, Pluristem Ltd., operates as a bio-therapeutics company in Israel. It focuses on the research, development, clinical trials, and manufacture of cell therapeutics products and related technologies for the treatment of various ischemic, inflammatory, and hematologic conditions. The company develops placenta expanded (PLX) cell therapy products, such as PLX-PAD cells, which has been completed Phase-II clinical trial for the treatment of peripheral and cardiovascular diseases, as well as for the treatment of orthopedic diseases. It also develops PLX-R18 cells for hematopoietic cell transplantation in animals, as well as conducts various in-vivo studies for the evaluation of PLX-R18 for the treatment of ARS. The company has collaborative research agreement with the Berlin-Brandenburg Center for Regenerative Therapies. Pluristem Therapeutics Inc. was founded in 2001 and is based in Haifa, Israel.
Xerium Technologies, Inc. (NYSE:XRM) finalized the last transaction at value of $6.40, with a daily change of -2.74% or -0.18 points. The company maintained volume of 83.39 thousand shares. In past trading day, the stock hit the maximum price of $6.58 and touched to minimum value of $6.30. It has a market cap of $ 103.37M.
As of last trade close, the stock is trading downside -30.13% from its one year high of $9.16 and moved +54.22% upward from $4.15, which is one year low of the stock.
The stock traded above +20.82% from its 50-day moving average of $5.30. Furthermore, the stock moved up +2.77% to its 200-day MA of $ 6.23.
During the last month, Xerium Technologies, Inc.’s (XRM) has changed 20.75% and performed -19.19% over the last 6 months. The mean rating score for this stock is at 2.00. This rating scale contains from 1 to 5 with 5 representing a Strong Sell, 1 signifying a Strong Buy and 3 demonstrating a Hold. The Volatility was noted at 5.35% in recent month and observed Weekly Volatility of 7.70%.